Ticker Details
Abeona Therapeutics Inc. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
IPO Date:	November 9, 1984
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$348.25M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 4.05%
Avg Daily Range (30 D):	$0.22 | 3.25%
Avg Daily Range (90 D):	$0.16 | 2.56%

Institutional Daily Volume
Avg Daily Volume:	.87M
Avg Daily Volume (30 D):	1.39M
Avg Daily Volume (90 D):	1.18M

Trade Size
Avg Trade Size (Sh.):	210
Avg Trade Size (Sh.) (30 D):	107
Avg Trade Size (Sh.) (90 D):	110

Institutional Trades
Total Institutional Trades:	449
Avg Institutional Trade:	$1.4M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$.88M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.63M
Avg Closing Trade (30 D):	$.68M
Avg Closing Trade (90 D):	$.9M
Avg Closing Volume:	61.23K

News

Jul 1, 2026 @ 11:30 AM Abeona Therapeutics® Announces New Employee Ind... Source: Na

Dec 31, 2025 @ 12:30 PM Abeona Therapeutics® Announces New Employee Ind... Source: Na

Nov 12, 2025 @ 4:37 PM Here's Why Abeona Therapeutics Popped Higher Today... Source: Lee Samaha

Sep 2, 2025 @ 8:59 AM Trends & Growth Strategies in the $13.5 Billion Ca... Source: Researchandmarkets.Com

Aug 12, 2025 @ 2:00 PM AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 ... Source: Dea Belazi

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.35	$-.3
Diluted EPS		$-.35	$-.3
Revenue		$11.38M	$8.72M
Gross Profit
Net Income / Loss		$-20.19M	$-17.08M
Operating Income / Loss		$-13.65M	$-23.03M
Cost of Revenue
Net Cash Flow		$-5.15M	$-17.06M
PE Ratio

Splits
Jul 05, 2022	1:25
Oct 24, 2014	1:50
Jun 05, 2006	1:5